BioCentury | Feb 15, 2010
Clinical News

NOVade: Phase II data

...University, which spun out Nometics in 2006 to develop technology relating to low-dose nitric oxide. Nometics Inc....
Items per page:
1 - 1 of 1
BioCentury | Feb 15, 2010
Clinical News

NOVade: Phase II data

...University, which spun out Nometics in 2006 to develop technology relating to low-dose nitric oxide. Nometics Inc....
Items per page:
1 - 1 of 1